PCDHA5: A Protein of Interest for Cancer and Drug Targets (G56143)

Target Name: PCDHA5

NCBI ID: G56143

PCDHA5

PCDHA5: A Protein of Interest for Cancer and Drug Targets

PCDHA5 (Perinod sarcoma viral homolog A5) is a protein that is expressed in a variety of tissues throughout the body, including the skin, hair, and nails. It is also a known gene that has been implicated in the development of certain types of cancer. In recent years, researchers have been interested in PCDHA5 as a potential drug target or biomarker, and a number of studies have been conducted to investigate its potential uses in these areas.

One of the main reasons for the interest in PCDHA5 is its potential as a drug target. PCDHA5 has been shown to play a role in the development of various types of cancer, including skin, lung, and ovarian cancer. Studies have also suggested that PCDHA5 may be involved in the regulation of cell growth and differentiation, which could make it an attractive target for drugs that are designed to inhibit its activity. Additionally, PCDHA5 has been shown to interact with a number of other proteins, including the TGF-β signaling pathway, which is involved in cell growth and differentiation. This suggests that targeting PCDHA5 may be a way to target a wide range of cellular processes that are important for cancer development.

Another potential use of PCDHA5 as a biomarker is its ability to be expressed in a variety of tissues and cells, which makes it a potential candidate for use as a diagnostic marker in cancer. Studies have shown that PCDHA5 can be detected in a variety of cancer tissues, including skin, lung, and ovarian cancer. Additionally, the expression of PCDHA5 has been shown to be associated with the development of certain types of cancer, which could make it a useful biomarker for identifying patients at risk for these types of diseases.

In addition to its potential as a drug target and biomarker, PCDHA5 is also of interest as a potential therapeutic agent. Studies have shown that PCDHA5 has been shown to inhibit the activity of certain drugs, including inhibitors of the TGF-β signaling pathway. This suggests that PCDHA5 may be a useful target for drugs that are designed to inhibit its activity and potentially treat a wide range of diseases. Additionally, the ability of PCDHA5 to interact with other proteins suggests that it may be a useful target for drugs that are designed to target a wide range of cellular processes.

Overall, PCDHA5 is a protein that has generated a lot of interest in recent years as a potential drug target and biomarker. Its ability to play a role in the development of various types of cancer and its potential as a therapeutic agent make it an attractive target for further investigation. As research continues to progress, it is likely that we will learn more about the role of PCDHA5 in cancer development and the potential uses of this protein.

Protein Name: Protocadherin Alpha 5

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHA5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHA5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets